HighTower Advisors, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 121 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$589,000
-2.3%
28,716
-5.3%
0.00%0.0%
Q2 2023$603,000
-76.2%
30,329
-79.5%
0.00%
-83.3%
Q1 2023$2,531,000
+39.9%
147,729
+59.6%
0.01%
+50.0%
Q4 2022$1,809,000
+312.1%
92,554
+237.2%
0.00%
+300.0%
Q3 2022$439,000
+5.5%
27,447
-8.8%
0.00%0.0%
Q2 2022$416,000
+23.8%
30,100
+43.3%
0.00%0.0%
Q1 2022$336,000
-4.3%
21,000
+30.3%
0.00%0.0%
Q4 2021$351,000
-23.7%
16,121
+5.0%
0.00%0.0%
Q3 2021$460,000
-35.8%
15,360
-5.0%
0.00%
-50.0%
Q2 2021$716,000
-4.5%
16,160
-4.7%
0.00%0.0%
Q1 2021$750,000
-25.1%
16,950
-7.0%
0.00%
-50.0%
Q4 2020$1,001,000
+93.2%
18,233
-19.7%
0.00%
+33.3%
Q3 2020$518,000
+13.1%
22,700
+3.7%
0.00%
+50.0%
Q2 2020$458,000
+28.7%
21,900
-13.9%
0.00%0.0%
Q1 2020$356,000
-35.5%
25,450
+5.2%
0.00%
-33.3%
Q4 2019$552,000
+265.6%
24,200
+142.0%
0.00%
+200.0%
Q2 2019$151,000
-14.2%
10,0000.0%0.00%0.0%
Q1 2019$176,000
-58.3%
10,000
-53.1%
0.00%
-66.7%
Q2 2018$422,00021,3440.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders